Changes to the website
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of changes to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 5069

Next 25
Website Changes
09/18/2020 Treatment Outcomes of Persistent Radiation-Induced Alopecia in Patients With Cancer
09/17/2020 Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control
09/14/2020 2nd Annual Brain Tumor TOGETHER and ACTION Day
09/11/2020 Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery
09/09/2020 New Webinar Added: Assessment of Treatment Response to Established and Novel Therapies in Glioblastoma Patients using Metabolic and Physiologic MR Imaging Techniques
09/02/2020 Return to work following diagnosis of low-grade glioma
08/31/2020 Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
08/29/2020 Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
08/25/2020 GT Medical Technologies Announces Data Demonstrating Positive Local Control and Safety Outcomes with GammaTile Therapy for Large Brain Metastases
08/24/2020 Phase I trial of convection-enhanced delivery of IL13RA2 and EPHA2 receptor targeted cytotoxins in dogs with spontaneous intracranial gliomas
08/24/2020 The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma
08/24/2020 A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
08/24/2020 Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme
08/23/2020 Ketone-Supressing Drug Combats Rare Brain Cancer in Mice
08/23/2020 Northwell neurosurgeon first on Long Island to use Modus V™ 3D exoscope to remove brain tumor
08/23/2020 ERC Announces Interim Results from Phase 2 Trial of Immunotherapy ERC1671 (Gliovac) in Recurrent Glioblastoma Patients
08/17/2020 Amazon Smile Fundraiser! Action Required!
08/17/2020 Promising Pathway Act Update.
08/12/2020 Brain Tumor Survey
07/31/2020 New video added: Metastatic Brain Tumors
07/30/2020 Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
07/29/2020 An Emerging Medical Market Play with Great Opportunity
07/29/2020 OncoSynergy has joined forces with the Musella Foundation For Brain Tumor Research & Information, Inc
07/28/2020 Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
07/28/2020 Dianhydrogalactitol (Val-083) synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740